Lea Marie's journey to a diagnosis was a decade-long ordeal that began in college with fainting spells she attributed to fatigue. A doctor's diagnosis of anxiety and a prescription for medication provided temporary relief, but her symptoms progressively worsened over the next ten years.
During this period, Marie moved and advanced her career as a data scientist. However, her health declined, and the fainting episodes evolved into seizures. She described experiencing alarming symptoms such as tunnel vision, tingling in her mouth and tongue, sweating, heart palpitations, and blackouts, particularly during a frightening episode while pregnant and with her infant daughter present.
Seeking Answers
After the birth of her second child, Marie decided to take control of her health, motivated by the desire to be present for her children. She sought a more comprehensive understanding of her body's issues. Her search led her to schedule a whole-body MRI at Prenuvo. The scan revealed a lesion in her brain, which, at the time, was not considered an immediate emergency.
Prenuvo referred her to a neurologist, who conducted a second MRI with contrast. This scan confirmed the presence of the lesion and recommended a follow-up in three months. By the time of the next scan, the lesion had grown, prompting immediate referrals to oncology and neurosurgery.
Marie was diagnosed with a low-grade glioma, a type of cancerous brain tumor that typically grows slowly and affects individuals between 20 and 40 years old. Despite the diagnosis, she expressed a sense of relief, noting that it was not a more aggressive glioblastoma or a stage four tumor. She shared that low-grade gliomas have a high survival rate, with up to 96% of patients surviving over five years, a stark contrast to glioblastomas where median survival is 12-18 months and only 6% survive five years or more.
A Cautious Treatment Approach
The location of Marie's tumor, in the temporal lobe, presents a complex surgical challenge. This area of the brain is critical for language and memory. The risk of losing speech or memory function, especially as she is bilingual, makes surgery a high-stakes option that doctors aim to postpone.
Currently, Marie's medical team is employing a "watch-and-wait" strategy, involving regular monitoring through MRI scans and clinical checkups. This approach is chosen because the tumor is not severely impacting her life, and the risks of aggressive treatment might outweigh the benefits.
If intervention becomes necessary, an "awake craniotomy" is a potential future procedure. This surgery involves the patient remaining conscious to allow surgeons to monitor brain function in real-time. While daunting, it is an option to preserve critical cognitive abilities.
For the time being, Marie manages her epilepsy with medication, which has significantly improved her quality of life, enabling her to resume an active lifestyle, including running marathons. She also has a rescue medication to manage seizure emergencies.
Sharing Her Experience
Marie does not harbor resentment towards the doctor who initially misdiagnosed her, attributing the delay to the natural evolution of medical accessibility and understanding over the past decade. She emphasizes her gratitude for her current life, family, and career.
She has chosen to share her experience by posting videos online, aiming to connect with and support others facing similar challenges. Marie believes that building a community of shared experience can alleviate the isolation that often accompanies serious illness.